Fundraising FoxGenetix Biotherapeutics Inc.
2 known investors
Find your way into Genetix Biotherapeutics Inc.
Sign up to see every warm intro you have to Genetix Biotherapeutics Inc.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Genetix Biotherapeutics Inc. team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Genetix Biotherapeutics develops gene addition therapies that use a patient's own cells to treat the underlying cause of rare diseases with a single dose, with a focus on hematology conditions such as sickle cell disease. The company has three FDA-approved one-time treatments for rare diseases.
Investors · 2
SK Capital Partnerslisted by SK Capital PartnersNew York
How we know: SK Capital Partners's portfolio page · Not right? Tell us
Third Rock VenturesreportedBoston · $100K – $5M
How we know: a partner's Signal profile · Not right? Tell us
Frequently asked questions
- What does Genetix Biotherapeutics Inc. do?
- Genetix Biotherapeutics develops gene addition therapies that use a patient's own cells to treat the underlying cause of rare diseases with a single dose, with a focus on hematology conditions such as sickle cell disease. The company has three FDA-approved one-time treatments for rare diseases.
- Who are Genetix Biotherapeutics Inc.'s investors?
- Genetix Biotherapeutics Inc.'s investors include SK Capital Partners, Third Rock Ventures.